Furthermore, we document that a dual p300/BRD4 inhibitor NEO273452,53 suppressed T-ALL cell growth with a 3–10-fold lower IC50 compared to JQ1 or CCS1477 alone (Fig. 4l). This evidence concerns the gene EP300 and acute lymphoblastic leukemia.